MTUSD:PA:PA-BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF USD Capitalisation (USD)

ETF | Others |

Last Closing

USD 10.07

Change

+0.05 (+0.53)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.57 (-1.25%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-5.10 (-0.97%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-3.96 (-1.04%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

-0.27 (-0.78%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.11 (-0.04%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-1.10 (-0.24%)

USD 7.99B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.65 (-0.77%)

USD 7.49B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.01 (-0.14%)

USD 7.42B
HHH:PA HSBC S&P 500 UCITS ETF

-0.53 (-0.99%)

USD 7.22B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-1.87 (-2.22%)

USD 5.38B

ETFs Containing MTUSD:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.09% 66% D+ 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.09% 66% D+ 57% F
Trailing 12 Months  
Capital Gain -2.07% 15% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.07% 14% F 40% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.93% 25% F 43% F
Dividend Return 1.93% 24% F 40% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.02% 85% B 94% A
Risk Adjusted Return 38.38% 30% F 55% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.